{"mainPropery":{"diseaseId":7499,"diseaseName":"Autoimmune pulmonary alveolar proteinosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7499/autoimmune-pulmonary-alveolar-proteinosis","synonyms":["PAP","Pulmonary alveolar lipoproteinosis acquired","PAP acquired","Pulmonary alveolar proteinosis autoimmune","Pulmonary alveolar proteinosis acquired","Acquired pulmonary alveolar proteinosis"],"synonyms-with-source":[{"name":"PAP"},{"name":"Pulmonary alveolar lipoproteinosis acquired"},{"name":"PAP acquired"},{"name":"Pulmonary alveolar proteinosis autoimmune"},{"name":"Pulmonary alveolar proteinosis acquired","source":"Previous preferred term"},{"name":"Acquired pulmonary alveolar proteinosis","source":"OMIM"}],"identifiers":[{"identifierType":"OMIM","identifierId":"610910"},{"identifierType":"ORPHANET","identifierId":"747"}]},"diseaseCategories":[{"diseaseTypeId":21,"diseaseTypeName":"Lung Diseases","source":"Orphanet"}],"organizations":[{"resourceID":3306,"resourceName":"Pulmonary Alveolar Proteinosis Foundation","abbreviation":"","address1":"3333 Burnet Avenue ","address2":"CCRF R4029","address3":"","address4":"","address5":"","city":"Cinncinnati","state":"OH","zip":"45229-3039","country":"United States","phone":"(844) CURE-PAP  FAX: (513) 636-3723","tty":"","tollFree":"","fax":"(513) 636-3723","email":"info@papfoundation.org","url":"https://www.papfoundation.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/610910' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?itool=omim_Detailed&DbFrom=omim&Cmd=Link&LinkName=omim_pubmed_calculated&IdsFromResult=610910' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Autoimmune pulmonary alveolar proteinosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://clinicaltrials.gov/ct2/results?term=pulmonary+alveolar+proteinosis+' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Autoimmune pulmonary alveolar proteinosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":42,"resourceId":916,"resourceName":"RDCRN - Rare Lung Diseases Consortium","descriptionText":"<p><a target=\"_blank\" href=\"https://www.rarediseasesnetwork.org/rldc/index.htm\">The&nbsp;Rare Lung Diseases Consortium: Molecular Pathway-Driven Diagnostics and Therapeutics for Rare Lung Diseases</a> is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research involving pulmonary alveolar proteinosis, Hermansky-Pudlak Syndrome, and Lymphangioleiomyomatosis. A pilot project program supports research into other rare lung diseases that complement the main research projects.</p>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":111,"resourceId":972,"resourceName":"Centers for Mendelian Genomics","descriptionText":"The <a href='http://mendelian.org/' target='_blank'>Centers for Mendelian Genomics</a> program is working to discover the causes of rare genetic disorders. For more information about applying to the research study, please visit their website.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/594/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000114.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/300615-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=747' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merckmanuals.com/home/sec04/ch048/ch048f.html?qt=pulmonary%20alveolar%20proteinosis&alt=sh' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2085,"resourceId":3305,"resourceName":"Yahoo group Pulmonary Alveolar Proteinosis","descriptionText":"A&nbsp;<a href='https://groups.yahoo.com/neo/groups/pulmonarypap/info' target='_blank'>Yahoo Group</a> is available for pulmonary alveolar proteinosis. You can connect with others through this forum. GARD does not monitor their messages, so please use your own discretion when using  this group.&nbsp;","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":2086,"resourceId":3306,"resourceName":"Pulmonary Alveolar Proteinosis Foundation","descriptionText":"A page&nbsp;<a href='http://www.papfoundation.org/forindividualswithpap.html' target='_blank'>For Individuals with PAP</a> is available from the PAP Foundation. This page covers frequently asked questions about the condition. Please note: this organization appears to be inactive, so the page may not be kept up-to-date.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:610910' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":4751,"questionText":"What is autoimmune pulmonary alveolar proteinosis?","answerText":"<strong>Autoimmune&nbsp;pulmonary alveolar proteinosis (aPAP)&nbsp;</strong>is a rare&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/autoimmunediseases.html\" target=\"_blank\">autoimmune</a>&nbsp;lung disorder. It is the&nbsp;most common form (90% of the cases) of <a href=\"https://rarediseases.org/rare-diseases/pulmonary-alveolar-proteinosis/\" target=\"_blank\">pulmonary alveolar proteinosis</a> (PAP).&nbsp;Most cases affect adults between the ages of 20-50 years.  Some people may not show symptoms, while others may have progressive difficulty breathing and shortness of breath upon exertion. Other signs and symptoms may include a dry, chronic cough; fatigue; weight loss; chest pain; and a general feeling of ill health. In rare cases,  coughing up of blood, rounding and swelling of the tips of the fingers, and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003215.htm\" target=\"_blank\">cyanosis</a> may be present.[3716] Autoimmune PAP is caused by an immune system malfunction, due to <a href=\"http://kidshealth.org/en/parents/test-immunoglobulins.html\" target=\"_blank\">IgG antibodies</a><span>&nbsp;that block the granulocyte-Macrophage Colony Stimulating Factor (</span><span>GM-CSF) effect. GM-CSF is a protein that regulates clearance of surfactant (a mix of protein and fat) by alveolar macrophages.&nbsp;The&nbsp;</span>surfactant pile up in the air sacs of the lungs (alveoli), and &nbsp;eventually lead to an inability to breath.[3716][12978] The standard treatment is a procedure called <a href=\"https://health.clevelandclinic.org/2014/08/how-lung-washing-helps-patients-breathe-again-video/\" target=\"_blank\">lung lavage</a>. A   drug called GM-CSF might effectively treat aPAP.[12978]<br />\r\n<br />\r\nOther PAP forms include&nbsp;<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/4582/Congenital_pulmonary_alveolar_proteinosis.aspx\" target=\"_blank\">congenital PAP</a>, a very rare form that occurs in some newborns, caused by d<span>isorders of surfactant production;</span>&nbsp;<a href=\"https://www.papfoundation.org/faq\" target=\"_blank\">hereditary PAP</a>, where people are born with genetic mutations that destroy the function of the proteins (receptors) on alveolar macrophages that interact with GM-CSF; and,&nbsp;<a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=23102\" target=\"_blank\">secondary PAP</a>, which occur in people with another disease or dust exposure.[3716][12978]<br />\r\n<br />","dateModified":"2017-01-27T00:00:00"},"basicQuestions":[{"questionId":4752,"questionText":"How might autoimmune pulmonary alveolar proteinosis be treated?","answerText":"The treatment of PAP varies from case to case depending upon the form of PAP and the age of an affected individual and severity of the disease. &nbsp;About one-third of individuals with idiopathic PAP (of unknown cause)&nbsp;will improve without treatment (spontaneous remission).&nbsp;<br />\r\n<br />\r\nPatients with moderate or severe respiratory problems due to autoimmune PAP can be treated by a whole lung lavage, a procedure in which one lung is cleansed with a salt solution while the other is pumped with pure oxygen. In some cases, the procedure may need to be performed once; in others it may need to be repeated many times over several years.[3716] Generally, one lung is lavaged in the first procedure, followed by lavage of the opposite lung one to two weeks later.[3716][3717] <br />\r\n<br />\r\nA treatment using recombinant granulocyte macrophage-colony stimulating factor (GM-CSF)&nbsp;given by nose, or with a subcutaneous injection is not approved for use in autoimmune PAP yet, but soon may be an effective option.[3716][3717][12979]&nbsp;<br />\r\n<br />\r\nLung transplantation has been used to treat adults with PAP as a last resort. According to the medical literature, in some cases, PAP has recurred in adults who have received lung transplantation.[3716]<br />\r\n<br />\r\n<span>Treatment options for patients with secondary and hereditary PAP are less clear and depend in part on the specific cause.</span><span style=\"font-size: 14.4px; font-family: Arial, 'Helvetica Neue', Helvetica, sans-serif;\">&nbsp;</span>In secondary PAP,&nbsp;removal and avoidance of the causative agent (e.g., silica exposure) or treatment of the underlying disorder may improve symptoms.[3716]&nbsp;<span>For neonates with severe congenital PAP, lung transplantation is the only treatment that appears to improve outcome.[12979][12980]</span>","dateModified":"2017-01-27T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":3716,"authors":"","articleTitle":"Pulmonary Alveolar Proteinosis","bookWebsiteJournalTitle":"NORD","date":"May 6, 2008","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/594/viewAbstract","dateAccessed":"2011-07-03T00:00:00"},{"referenceId":3717,"authors":"Allen J. Blaivas","articleTitle":"Pulmonary Alveolar Proteinosis","bookWebsiteJournalTitle":"MedlinePlus","date":"May 21, 2009","url":"http://www.nlm.nih.gov/medlineplus/ency/article/000114.htm","dateAccessed":"2011-07-03T00:00:00"},{"referenceId":12979,"authors":"Chan ED & King Jr TE","articleTitle":"Treatment and prognosis of pulmonary alveolar proteinosis in adults","bookWebsiteJournalTitle":"UpToDate","date":"May, 2017","volume":"","pages":"","url":"http://www.uptodate.com/contents/treatment-and-prognosis-of-pulmonary-alveolar-proteinosis-in-adults","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12980,"authors":"Vece TJ","articleTitle":"Pulmonary alveolar proteinosis in children","bookWebsiteJournalTitle":"UpToDate","date":"October 31, 2016","volume":"","pages":"","url":"http://www.uptodate.com/contents/pulmonary-alveolar-proteinosis-in-children","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":31339,"abbreviatedInquiry":"My brother-in-law has been diagnosed with this. What are the most common treatments or drugs for this condition? They plan to lavage the lungs. He has a history of chronic smoking.","caseQuestions":[{"questionId":4752,"questionText":"How might autoimmune pulmonary alveolar proteinosis be treated?","answerText":"The treatment of PAP varies from case to case depending upon the form of PAP and the age of an affected individual and severity of the disease. &nbsp;About one-third of individuals with idiopathic PAP (of unknown cause)&nbsp;will improve without treatment (spontaneous remission).&nbsp;<br />\r\n<br />\r\nPatients with moderate or severe respiratory problems due to autoimmune PAP can be treated by a whole lung lavage, a procedure in which one lung is cleansed with a salt solution while the other is pumped with pure oxygen. In some cases, the procedure may need to be performed once; in others it may need to be repeated many times over several years.[3716] Generally, one lung is lavaged in the first procedure, followed by lavage of the opposite lung one to two weeks later.[3716][3717] <br />\r\n<br />\r\nA treatment using recombinant granulocyte macrophage-colony stimulating factor (GM-CSF)&nbsp;given by nose, or with a subcutaneous injection is not approved for use in autoimmune PAP yet, but soon may be an effective option.[3716][3717][12979]&nbsp;<br />\r\n<br />\r\nLung transplantation has been used to treat adults with PAP as a last resort. According to the medical literature, in some cases, PAP has recurred in adults who have received lung transplantation.[3716]<br />\r\n<br />\r\n<span>Treatment options for patients with secondary and hereditary PAP are less clear and depend in part on the specific cause.</span><span style=\"font-size: 14.4px; font-family: Arial, 'Helvetica Neue', Helvetica, sans-serif;\">&nbsp;</span>In secondary PAP,&nbsp;removal and avoidance of the causative agent (e.g., silica exposure) or treatment of the underlying disorder may improve symptoms.[3716]&nbsp;<span>For neonates with severe congenital PAP, lung transplantation is the only treatment that appears to improve outcome.[12979][12980]</span>","dateModified":"2017-01-27T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":3716,"authors":"","articleTitle":"Pulmonary Alveolar Proteinosis","bookWebsiteJournalTitle":"NORD","date":"May 6, 2008","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/594/viewAbstract","dateAccessed":"2011-07-03T00:00:00"},{"referenceId":3717,"authors":"Allen J. Blaivas","articleTitle":"Pulmonary Alveolar Proteinosis","bookWebsiteJournalTitle":"MedlinePlus","date":"May 21, 2009","url":"http://www.nlm.nih.gov/medlineplus/ency/article/000114.htm","dateAccessed":"2011-07-03T00:00:00"},{"referenceId":12979,"authors":"Chan ED & King Jr TE","articleTitle":"Treatment and prognosis of pulmonary alveolar proteinosis in adults","bookWebsiteJournalTitle":"UpToDate","date":"May, 2017","volume":"","pages":"","url":"http://www.uptodate.com/contents/treatment-and-prognosis-of-pulmonary-alveolar-proteinosis-in-adults","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12980,"authors":"Vece TJ","articleTitle":"Pulmonary alveolar proteinosis in children","bookWebsiteJournalTitle":"UpToDate","date":"October 31, 2016","volume":"","pages":"","url":"http://www.uptodate.com/contents/pulmonary-alveolar-proteinosis-in-children","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":10172,"phenoTypeName":"Intraalveolar phospholipid accumulation","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5144,"phenoTypeName":"Abnormal circulating protein level","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13720,"phenoTypeName":"Abnormality of the upper respiratory tract","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":1184,"phenoTypeName":"Autoimmune antibody positivity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3063,"phenoTypeName":"Clubbing","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10281,"phenoTypeName":"Cyanosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6771,"phenoTypeName":"Decreased DLCO","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13726,"phenoTypeName":"Dyspnea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5239,"phenoTypeName":"Foam cells","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2440,"phenoTypeName":"Hypoxemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2176,"phenoTypeName":"Increased lactate dehydrogenase level","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13724,"phenoTypeName":"Restrictive ventilatory defect","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9070,"phenoTypeName":"Cough","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2354,"phenoTypeName":"Crackles","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12444,"phenoTypeName":"Crazy paving pattern on pulmonary HRCT","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1101,"phenoTypeName":"Anti-granulocyte-macrophage colony stimulating factor antibody positivity","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":1176,"phenoTypeName":"Brain abscess","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11831,"phenoTypeName":"Chest pain","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13704,"phenoTypeName":"Fatigue","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13737,"phenoTypeName":"Hemoptysis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":12048,"phenoTypeName":"Inspiratory crackles","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":2817,"phenoTypeName":"Lung abscess","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5059,"phenoTypeName":"Weight loss","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6244,"phenoTypeName":"Insidious onset","percentRanges":"-"},{"phenoTypeId":13723,"phenoTypeName":"Pneumonia","percentRanges":"-"},{"phenoTypeId":8075,"phenoTypeName":"Recurrent respiratory infections","percentRanges":"-"},{"phenoTypeId":5315,"phenoTypeName":"Sporadic","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Autoimmune_pulmonary_alveolar_proteinosis"}